US9744144 — Method of treating cardiovascular events using colchicine concurrently with an antiplatelet agent
Method of Use · Assigned to Murray and Poole Enterprises Ltd · Expires 2033-11-01 · 7y remaining
What this patent protects
Methods are provided for treating and/or preventing a cardiovascular event in a patient by orally administering colchicine while the patient is also receiving an antiplatelet agent.
USPTO Abstract
Methods of treating and/or preventing a cardiovascular event in a patient, the method comprising orally administering a colchicine to a patient who is receiving concurrent treatment with at least one antiplatelet agent, thereby treating and/or preventing the cardiovascular event in the patient are provided.
Drugs covered by this patent
- Colcrys (COLCHICINE) · Scilex Pharms
FDA Patent Use Codes
When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.
| Code | Description | Drug |
|---|---|---|
U-3643 |
— | Colcrys |
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.